Levetiracetam Generis (Levetiracetam)

Levetiracetam exerts its anticonvulsant effect by binding to the synaptic vesicle protein SV2A. This binding modulates neurotransmitter release, stabilizing neuronal firing and decreasing hyperexcitability in the brain, which in turn helps prevent the initiation and spread of seizure activity.

The appropriate dose of Levetiracetam Generis is determined by the prescribing clinician based on the patient’s age, renal function, seizure type, and response to therapy. Dosage adjustments may be required for special populations, and the prescriber will provide individualized instructions.

Safety data for levetiracetam in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Clinicians should weigh the potential benefits against possible risks and discuss options with the patient. Breastfeeding decisions should also be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will respond with pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It is generally well tolerated, has minimal drug‑enzyme interactions, and does not require routine therapeutic monitoring, making it a convenient option for many patients.

Levetiracetam Generis should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Levetiracetam Generis is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with a glass of water. If a patient has difficulty swallowing, the prescriber may consider an alternative formulation.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, psychiatric events like depression or suicidal thoughts, and rare blood disorders. Patients should be instructed to seek immediate medical attention if they experience rash, mood changes, or signs of infection.

Levetiracetam Generis is contraindicated in individuals with a known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment who have not had dose adjustments, and for those with a history of serious psychiatric disorders.